Catalog No.:AA001K4P

1448-87-9 | 2-Chloroquinoxaline

Name: Name:2-Chloroquinoxaline
Brand: AABLOCKS
SKU: AA001K4P
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

250mg

98%

in stock

$6.00 $4.00

- +

98%

in stock

$7.00 $5.00

- +

98%

in stock

$14.00 $10.00

- +

10g

95%

in stock

$15.00 $10.00

- +

25g

95%

in stock

$30.00 $21.00

- +

Technical Information
Properties
Upstream Synthesis Route
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Upstream Synthesis Route
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA001K4P

Chemical Name:

2-Chloroquinoxaline

CAS Number:

1448-87-9

Molecular Formula:

C8H5ClN2

Molecular Weight:

164.5917

MDL Number:

MFCD00043907

SMILES:

Clc1cnc2c(n1)cccc2

NSC Number:

43553

Properties

BP:

252.9°C at 760 mmHg

Form:

Solid

MP:

47-50 °C(lit.)

Refractive Index:

1.5500 (estimate)

Storage:

Keep in dry area;Room Temperature;

Computed Properties

Complexity:

140

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

XLogP3:

2.2

Upstream Synthesis Route

1448-87-9

5424-05-5

[1]AngewandteChemie-InternationalEdition,2015,vol.54,#12,p.3773-3777

[2]Angew.Chem.,2015,vol.127,#12,p.3844-3848,5

[3]OrganicLetters,2013,vol.15,#14,p.3734-3737

[4]Tetrahedron,2010,vol.66,#34,p.6958-6964

[5]Patent:US2003/69284,2003,A1,

[6]JournaloftheChemicalSociety,1945,p.622,625

[7]Patent:US2537870,1946,,

1196-57-2

1448-87-9

[1]Patent:US2017/143706,2017,A1,.Locationinpatent:Paragraph0050;0106;0107

[2]HelveticaChimicaActa,2001,vol.84,#5,p.1112-1118

[3]Heterocycles,2005,vol.65,#1,p.181-185

[4]Heterocycles,2006,vol.68,#9,p.1973-1979

[5]JournaloftheChemicalSociety,1945,p.622,625

[6]JournaloftheChemicalSociety,1957,p.3236,3237

[7]BulletindelaSocieteChimiquedeFrance,1959,p.1793,1796

[8]Patent:US2537870,1946,,

[9]Heterocycles,1985,vol.23,#10,p.2603-2611

[10]ChemistryLetters,1984,p.323-326

[11]Heterocycles,2012,vol.86,#2,p.1583-1590

1196-57-2

1448-87-9

[1]Molecules,2012,vol.17,#4,p.4533-4544

[2]ChemMedChem,2015,vol.10,#1,p.193-206

[3]Patent:CN103787992,2016,B,.Locationinpatent:Paragraph0079-0082

[4]Patent:CN107602539,2018,A,.Locationinpatent:Paragraph0043

[5]Patent:CN108530435,2018,A,.Locationinpatent:Paragraph0015;0017

[6]TetrahedronLetters,1999,vol.40,#42,p.7477-7478

[7]SyntheticCommunications,2005,vol.35,#15,p.1983-1987

[8]SyntheticCommunications,2011,vol.41,#23,p.3532-3540

[9]Chemistry-AEuropeanJournal,2009,vol.15,#19,p.4857-4864

[10]JournalofMedicinalChemistry,2011,vol.54,#13,p.4508-4522

[11]RevueRoumainedeChimie,2017,vol.62,#12,p.903-906

[12]JournalofPhysicalOrganicChemistry,1994,vol.7,#10,p.545-550

[13]JournalofOrganicChemistry,2003,vol.68,#5,p.2054-2057

[14]BioorganicandMedicinalChemistryLetters,2007,vol.17,#24,p.6723-6728

[15]Patent:US4076806,1978,A,

[16]MedicinalChemistryResearch,2013,vol.22,#4,p.1660-1673

6935-29-1

1448-87-9

[1]Tetrahedron,2016,vol.72,#38,p.5762-5768

[2]JournaloftheChemicalSociety,1953,p.2816,2819

5227-59-8

1448-87-9

[1]TetrahedronLetters,2010,vol.51,#42,p.5516-5520

Downstream Synthesis Route

1448-87-9

5424-05-5

[1]AngewandteChemie-InternationalEdition,2015,vol.54,p.3773-3777 Angew.Chem.,2015,vol.127,p.3844-3848,5

[2]OrganicLetters,2013,vol.15,p.3734-3737

[3]Tetrahedron,2010,vol.66,p.6958-6964

[4]Patent:US2003/69284,2003,A1

[5]JournaloftheChemicalSociety,1945,p.622,625

1448-87-9

61645-34-9

[1]Heterocycles,1985,vol.23,p.2603-2611

[2]BioorganicandMedicinalChemistryLetters,2014,vol.24,p.934-939

[3]Bioorganicandmedicinalchemistryletters,2019

[4]JournalofOrganicChemistry,2008,vol.73,p.900-911

[5]Patent:US2012/264704,2012,A1.Locationinpatent:Page/Pagecolumn17

[6]TetrahedronLetters,2020

[7]YakugakuZasshi/JournalofthePharmaceuticalSocietyofJapan,1958,vol.78,p.729,732 Chem.Abstr.,1958,p.18428

[8]Patent:WO2013/19548,2013,A1.Locationinpatent:Page/Pagecolumn66

1196-57-2

1448-87-9

[1]Patent:US2017/143706,2017,A1.Locationinpatent:Paragraph0050;0106;0107

[2]HelveticaChimicaActa,2001,vol.84,p.1112-1118

[3]Heterocycles,2005,vol.65,p.181-185

[4]Heterocycles,2006,vol.68,p.1973-1979

[5]Molecules,2019,vol.24

[6]JournaloftheChemicalSociety,1945,p.622,625

[7]Patent:US2537870,1946,

[8]Heterocycles,1985,vol.23,p.2603-2611

[9]ChemistryLetters,1984,p.323-326

[10]Heterocycles,2012,vol.86,p.1583-1590

6935-29-1

1448-87-9

[1]Tetrahedron,2016,vol.72,p.5762-5768

[2]JournaloftheChemicalSociety,1953,p.2816,2819

20254-76-6

1448-87-9

[1]JournaloftheChemicalSociety,1945,p.622,625

Literature

Title: 2-(3-Nitro-phen-oxy)quinoxaline.

Journal: Acta crystallographica. Section E, Structure reports online 20100901

Title: 1-Naphthyl quinoxalin-2-yl ether.

Journal: Acta crystallographica. Section E, Structure reports online 20090401

Title: 2-Naphthyl quinoxalin-2-yl ether.

Journal: Acta crystallographica. Section E, Structure reports online 20090401

Title: 2-Chloro-quinoxaline.

Journal: Acta crystallographica. Section E, Structure reports online 20090301

Title: Phenyl quinoxalin-2-yl ether.

Journal: Acta crystallographica. Section E, Structure reports online 20080901

Title: Quinoxalin-2-yl o-tolyl ether.

Journal: Acta crystallographica. Section E, Structure reports online 20080901

Title: Quinoxalin-2-yl m-tolyl ether.

Journal: Acta crystallographica. Section E, Structure reports online 20080901

Title: Quinoxalin-2-yl p-tolyl ether.

Journal: Acta crystallographica. Section E, Structure reports online 20080901

Title: Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20060315

Title: Preparation of nitrogen-containing pi-deficient heteroaromatic Grignard reagents: oxidative magnesiation of nitrogen-containing pi-deficient halogenoheteroaromatics using active magnesium.

Journal: The Journal of organic chemistry 20030307

Title: Synthesis of new arylaminoquinoxalines and their antimalarial activity in mice.

Journal: The Journal of pharmacy and pharmacology 20011001

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS